Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Vir Biotechnology Inc (VIR)
Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,172,697
  • Shares Outstanding, K 133,531
  • Annual Sales, $ 1,616 M
  • Annual Income, $ 515,840 K
  • 60-Month Beta 0.26
  • Price/Sales 1.96
  • Price/Cash Flow 6.13
  • Price/Book 1.52
Trade VIR with:

Options Overview Details

View History
  • Implied Volatility 65.31% ( +15.09%)
  • Historical Volatility 50.64%
  • IV Percentile 35%
  • IV Rank 29.89%
  • IV High 114.76% on 04/29/22
  • IV Low 44.23% on 01/20/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 461
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 7,927
  • Open Int (30-Day) 7,497

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -0.80
  • Number of Estimates 5
  • High Estimate -0.24
  • Low Estimate -1.09
  • Prior Year 3.85
  • Growth Rate Est. (year over year) -120.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.02 +6.13%
on 02/24/23
28.07 -16.74%
on 02/22/23
-3.62 (-13.41%)
since 02/21/23
3-Month
22.02 +6.13%
on 02/24/23
31.55 -25.93%
on 01/27/23
-2.89 (-11.01%)
since 12/21/22
52-Week
18.05 +29.47%
on 09/23/22
31.78 -26.46%
on 07/13/22
-1.96 (-7.74%)
since 03/21/22

Most Recent Stories

More News
Stocks Rise on Strength in Apple and Lower Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.04%. U.S. stock...

$SPX : 3,981.65 (+0.76%)
SPY : 396.64 (+0.74%)
$DOWI : 32,403.80 (+0.49%)
DIA : 324.12 (+0.56%)
$IUXX : 12,654.60 (+0.73%)
QQQ : 308.29 (+0.76%)
AAPL : 158.58 (+0.75%)
DPZ : 316.56 (-0.20%)
CIEN : 49.91 (-0.58%)
CRWD : 134.97 (+1.68%)
EMR : 83.96 (+2.05%)
MRK : 105.28 (-0.54%)
Markets Today: Stock Indexes Push Higher on Weaker Bond Yields

Morning Markets March S&P 500 futures (ESH2 3) this morning are up +0.26%, and March Nasdaq 100 E-Mini futures (NQH2 3) are up +0.45%. U.S. stock index futures this morning are moderately higher. Apple...

ESM23 : 4,011.00 (+0.70%)
NQM23 : 12,775.75 (+0.69%)
AAPL : 158.58 (+0.75%)
CIEN : 49.91 (-0.58%)
MRK : 105.28 (-0.54%)
HCP : 29.81 (+1.46%)
VIR : 23.28 (-2.02%)
ARMK : 34.16 (+2.24%)
HGV : 44.75 (+3.49%)
AXTA : 28.65 (+2.72%)
VAL : 63.75 (+2.46%)
DHI : 96.69 (+0.06%)
Coronavirus Vaccine Market To Surpass $95 Billion By 2028

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 0.7960 (+2.05%)
MRNA : 153.45 (-0.69%)
NVAX : 6.07 (+1.51%)
VIR : 23.28 (-2.02%)
INO : 1.0650 (-0.47%)
Coronavirus Vaccine Market To Surpass $95 Billion By 2028

/PRNewswire/ -- The Coronavirus Global Market has been growing in the past few years and is anticipated to continue to grow in the next several years. In fact,...

SBFM : 0.7960 (+2.05%)
MRNA : 153.45 (-0.69%)
NVAX : 6.07 (+1.51%)
VIR : 23.28 (-2.02%)
INO : 1.0650 (-0.47%)
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Misses Revenue Estimates

Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of -1,800% and 80.07%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

VIR : 23.28 (-2.02%)
RETA : 89.84 (+0.51%)
Universal Health (UHS) to Post Q4 Earnings: What to Expect

Universal Health's (UHS) fourth-quarter results are likely to reflect an increase in same facility adjusted admissions in acute care hospitals.

UHS : 125.32 (+1.65%)
MRUS : 20.23 (+2.17%)
SIBN : 19.72 (+1.60%)
VIR : 23.28 (-2.02%)
Halozyme Therapeutics (HALO) Q4 Earnings Surpass Estimates

Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 2.13% and 2.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HALO : 34.62 (-0.57%)
VIR : 23.28 (-2.02%)
Select Medical (SEM) to Post Q4 Earnings: What to Expect

Select Medical's (SEM) fourth-quarter results are likely to reflect improved figures in the Rehabilitation Hospital business.

SEM : 25.44 (+0.71%)
MRUS : 20.23 (+2.17%)
SIBN : 19.72 (+1.60%)
VIR : 23.28 (-2.02%)
Stocks Set To Open Lower As Investors Await FOMC Minutes

March S&P 500 futures (ESH23) are trending down -0.72% this morning after three major U.S. benchmark indices closed mixed on Friday as the prospect of further monetary tightening from the Fed weighed on...

ESH23 : 3,957.05s (-0.09%)
GS : 318.19 (+2.80%)
BAC : 28.79 (+3.75%)
WMT : 139.75 (-0.82%)
HD : 289.68 (+0.15%)
BHP.LN : 2,378.500 (-0.36%)
SGML : 36.06 (-1.21%)
TSLA : 195.97 (+6.94%)
TEF : 4.11 (+3.01%)
VIR : 23.28 (-2.02%)
CF : 75.02 (+3.38%)
BMRN : 92.24 (-0.11%)
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth

BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BMRN : 92.24 (-0.11%)
VIR : 23.28 (-2.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus...

See More

Key Turning Points

3rd Resistance Point 25.39
2nd Resistance Point 24.92
1st Resistance Point 24.34
Last Price 23.28
1st Support Level 23.29
2nd Support Level 22.82
3rd Support Level 22.24

See More

52-Week High 31.78
Fibonacci 61.8% 26.54
Fibonacci 50% 24.92
Fibonacci 38.2% 23.29
Last Price 23.28
52-Week Low 18.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar